Identical microtablets maintain uniform distribution to resolve separation problems during mixing, enabling precise individual dosing.
Controlled slow infusion of sulcardine achieves effective cardioversion while preventing hypotensive effects and pro-arrhythmic risks.
Bardoxolone methyl activates Nrf2 and modulates endothelin signaling to reduce pulmonary artery pressure in cardiovascular disease treatment.
Phospholipid complexes form micelles that solubilize quercetin, overcoming low bioavailability and poor absorption in conventional formulations.
Reverse wet granulation processes poorly soluble APIs with hydrophilic polymers to prevent large agglomerates and ensure uniform erosion during dissolution.
Optimizing the dry binder particle size distribution reduces tablet friability to 0.3%, resolving mechanical property issues in high-levetiracetam formulations.
Magnesium and calcium salt compositions raise serum albumin without accelerating vascular calcification or metabolic acidosis.
Silicate-based adsorbent carrier binds oily active ingredients to prevent punch fouling during compression.
A pharmaceutical composition combines Cannabis sativa, Vanshlochan, and ashwagandha to provide synergistic pain relief.
A teriflunomide film-coated tablet uses specific excipients and controlled particle size to enhance dissolution.
Combining quinacrine and valproic acid induces apoptosis in acute myeloid leukemia cells through synergistic mechanisms.
Film-coated drug granules mask bitterness while excipients ensure tablet hardness, suppressing tableting failure at low compression forces.
A solid oral form uses a polymer blend coating on microparticles to control drug release timing and location.
High molecular weight binders in methazolamide formulations resolve compressibility issues while sustaining therapeutic serum levels for once-daily dosing.
Solvent extraction forms non-crystalline particles that overcome poor solubility and first-pass effects for targeted colon delivery.